Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus

Circulation

Volumn 110, Issue 2, 2004, Pages 214-219

  Esposito, Katherine ^a   Giugliano, Dario ^a,b   Nappo, Francesco ^a   Marfella, Raffaele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Policlinico Universitario   (Italy)

Author keywords

Atherosclerosis; Carotid arteries; Diabetes mellitus; Interleukins

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; GLIBENCLAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; METFORMIN; REPAGLINIDE; SULFONYLUREA;

ADULT; AGED; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VASCULITIS;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARBAMATES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; LIPIDS; MALE; MIDDLE AGED; PIPERIDINES; POSTPRANDIAL PERIOD; SINGLE-BLIND METHOD; TUNICA INTIMA; TUNICA MEDIA;

EID: 3142760075     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000134501.57864.66     Document Type: Article

References (25)

1. Lee WL, Cheung AM, Cape D, et al. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care. 2000;23:962-968.
2. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia. 2001;44:2107-2114.
3. American Diabetes Association. Consensus statement: postprandial blood glucose. Diabetes Care 2001;24:775-778.
4. O'Leary LH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22.
5. Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995;26:386-391.
6. Azen SP, Mack WJ, Cashin-Hemphill L, et al. Progression of coronary artery disease predicts clinical coronary events: long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation. 1996;93:34-41.
7. Wolffenbuttel BHR, Landgraf R, on behalf of the Dutch and German Repaglinide Study Group. A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Diabetes Care 1999;22:463-467.
8. Cozma LS, Luzio SD, Dunseath GJ, et al. Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal. Diabetes Care. 2002;25:1271-1276.
9. Schmitz O, Lund S, Andersen PH, et al. Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide. Diabetes Care. 2002;25:342-346.
10. American Diabetes Association. Position statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2003;26:51-61.
11. 1c levels. Diabetes Care. 2000;23:1830-1834.
12. Ceriello A, Quagliaro L, Catone B, et al. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care. 2002;25:1439-1443.
13. Giugliano D, Marfella R, Coppola L, et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: evidence for reduced availability of nitric oxide during hyperglycemia. Circulation. 1997;95:1783-1790.
14. Marfella R, Esposito K, Giunta R, et al. Circulating adhesion molecules in humans: a role of hyperglycemia and hyperinsulinemia. Circulation. 2000;101:2247-2251.
15. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067-2072.
16. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-1772.
17. Blankenberg S, Tiret L, Nickel C, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002;106:24-30.
18. Smith DA, Irving SD, Sheldom J, et al. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001;104:746-749.
19. Giugliano D, Ceriello A. The toxic trio: acute, chronic and post-prandial hyperglycemia. Nutr Metab Cardiovasc Dis. 2001;11:773-778.
20. Libby P, Plutzky J. Diabetic macrovascular disease: the glucose paradox. Circulation. 2002;106:2760-2763.
21. Hashimoto H, Kitagawa K, Hougaku H, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation. 1998;98:839-844.
22. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913-919.
23. Liu S, Manson JE, Buring JE, et al. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002;75:492-498.
24. Nappo F, Esposito K, Cioffi M, et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol. 2002;39:1145-1150.
25. Chiasson J-L, Josse RG, Gomis R, et al, for the STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA. 2003;290:486-494.